Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Vera Therapeutics
Over the past year NAMS returned −47.1% and VERA returned +8.9%; their daily moves had a correlation of 0.40.
NAMS −47.1% VERA +8.9%Growth of $1, one year, split-adjusted
| Metric | NAMS | VERA |
|---|---|---|
| Price | $20.06 | $30.98 |
| Market cap | $2.40B | $2.23B |
| Today | −3.37% | +1.47% |
| 1 month | −17.0% | 0.0% |
| 6 months | −29.4% | −12.0% |
| Year to date | −42.8% | −38.8% |
| 1 year | −44.0% | +5.5% |
| Revenue growth (YoY) | −80.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1732.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 336.7× | — |
| Net cash | $633.9M | $423.9M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 60.3% |
| Short % of float | 16.4% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).